• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR RX XIENCE XPEDITION 48; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR RX XIENCE XPEDITION 48; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1078250-48
Device Problems Difficult to Remove (1528); Improper or Incorrect Procedure or Method (2017); Failure to Advance (2524); Difficult to Advance (2920)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 08/11/2020
Event Type  malfunction  
Manufacturer Narrative
The customer reported the device is not returning.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.
 
Event Description
It was reported that the procedure was performed to treat a lesion with heavy calcification in the right coronary artery (rca).Pre-dilatation was performed.Then a 2.5 x 48mm xience xpedition stent delivery system (sds) was advanced; however, the sds failed to cross the target lesion due to the heavily calcified lesion.Therefore, an extension catheter was used, but the sds could not be advanced with the extension catheter.It was possible that the inside of the extension catheter was deformed.The sds was removed with resistance due to the anatomy.Another unspecified device was used to complete the procedure.There were no adverse patient effects and no clinically significant delay in the procedure.
 
Manufacturer Narrative
Device code 2017: improper or incorrect procedure or method.The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history did not indicate a lot specific quality issue.The investigation determined the reported difficulties appear to be related to the operational context of the procedure, as it is likely the device interacted with the heavily calcified anatomy during advancement, as resistance was noted, causing the reported failure to advance.Interaction with the guide catheter during advancement likely contributed to the reported difficult to advance/position, as the physician noted that the inside of the extension catheter may have been deformed.Further interaction with the challenging anatomy during retraction, as resistance was again noted, likely contributed to the reported difficult to remove.It should be noted that the xience xpedition, everolimus eluting coronary stent system instructions for use (ifu) states: an unexpanded stent may be retracted into the guiding catheter one time only.An unexpanded stent should not be reintroduced into the artery once it has been pulled back into the guiding catheter.Subsequent movement in and out through the distal end of the guiding catheter should not be performed, as the stent may be damaged when retracting the undeployed stent back into the guiding catheter.It is unknown if the ifu deviation contributed to the reported event.There is no indication of a product quality issue with respect to the design, manufacture or labeling of the device.Na.
 
Event Description
N/a.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RX XIENCE XPEDITION 48
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key10465402
MDR Text Key204715514
Report Number2024168-2020-07202
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 10/12/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/28/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/25/2022
Device Catalogue Number1078250-48
Device Lot Number9111541
Was Device Available for Evaluation? No
Date Manufacturer Received09/18/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-